Lumexa Imaging Holdings, Inc. (LMRI)
| Market Cap | 902.47M |
| Revenue (ttm) | 1.02B |
| Net Income (ttm) | -47.10M |
| Shares Out | 96.11M |
| EPS (ttm) | -0.66 |
| PE Ratio | n/a |
| Forward PE | 13.36 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 383,070 |
| Open | 9.62 |
| Previous Close | 9.71 |
| Day's Range | 9.11 - 9.67 |
| 52-Week Range | 7.23 - 19.45 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 20.75 (+120.98%) |
| Earnings Date | May 18, 2026 |
About LMRI
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina. [Read more]
Financial Performance
In 2025, Lumexa Imaging Holdings's revenue was $1.02 billion, an increase of 7.82% compared to the previous year's $948.87 million. Losses were -$47.10 million, -49.94% less than in 2024.
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for LMRI stock is "Strong Buy." The 12-month stock price target is $20.75, which is an increase of 120.98% from the latest price.
News
Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer
Proven healthcare growth leader to drive disciplined, profitable expansion and scale across Lumexa Imaging's platform Proven healthcare growth leader to drive disciplined, profitable expansion and sca...
Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Lumexa Imaging Holdings, Inc. (NASDAQ: LMRI). The investigation focuses o...
Lumexa Imaging Holdings Earnings Call Transcript: Q4 2025
Delivered strong Q4 and full-year 2025 growth, driven by advanced imaging, new center openings, and technology adoption. 2026 guidance reaffirms revenue and EBITDA growth, with continued focus on advanced modalities, geographic expansion, and operational efficiency.
Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance
RALEIGH, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced certain financial results for the...
Lumexa Imaging Holdings Transcript: Barclays 28th Annual Global Healthcare Conference
Outpatient imaging growth is driven by advanced modalities, technology investments, and targeted de novo expansion. Strong commercial payer mix, transparent JV reporting, and AI-driven workflow improvements support financial performance and capacity growth.
Lumexa Imaging Holdings Transcript: 47th Annual Raymond James Institutional Investor Conference
Radiology is seeing rapid growth and consolidation, with advanced imaging driving revenue and margin expansion. The company leverages JV partnerships, de novo openings, and a strong commercial payer mix to fuel growth, while maintaining high patient satisfaction and transparent financial reporting.
Lumexa Imaging Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results; Provides 2026 Financial Guidance and Earnings Conference Call Date
RALEIGH, N.C., March 2, 2026 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging" or "we"), one of the nation's largest providers of outpatient imaging services, today announced certain pre...
Lumexa Imaging Announces Participation in Upcoming Investor Conferences
RALEIGH, N.C., Feb. 17, 2026 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, announced today that...
Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered Care
Chair of Lumexa Imaging's Center for Quality will serve as the Radiological Society of North America's board liaison for government relations RALEIGH, N.C., Jan. 28, 2026 /PRNewswire/ -- Lumexa Imagin...
Lumexa Imaging Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference
Diagnostic imaging is a large, fast-growing, and fragmented market, with significant opportunities for expansion through de novo centers, joint ventures, and selective M&A. The business leverages technology and AI for efficiency, maintains high satisfaction rates, and targets consistent, capital-efficient growth.
Lumexa Imaging Achieves Record De Novo Expansion in 2025
Company opens nine new outpatient imaging centers, expanding access to high-quality, cost-effective care RALEIGH, N.C., Jan. 8, 2026 /PRNewswire/ -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's ...
Lumexa Imaging Announces Participation in Upcoming Investor Conference
RALEIGH, N.C., Jan. 5, 2026 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, announced today that ...
Lumexa Imaging valued at $1.76 billion as shares edge up in Nasdaq debut
Lumexa Imaging's shares rose marginally in their Nasdaq debut on Thursday, valuing the provider of diagnostic imaging services at $1.76 billion.
Welsh Carson-backed Lumexa Imaging raises $463 million in US IPO
Lumexa Imaging, one of the largest U.S. diagnostic imaging services providers, said on Wednesday it has raised $462.5 million in its initial public offering.
Lumexa Imaging Announces Pricing of Initial Public Offering
RALEIGH, N.C. , Dec. 10, 2025 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") announced today the pricing of its initial public offering of 25,000,000 shares of its common stock, par ...
Lumexa Imaging targets up to $1.89 billion valuation in US IPO
Lumexa Imaging is aiming for a valuation of more than $1.89 billion in its U.S. initial public offering, the Welsh Carson-backed said on Tuesday.
Lumexa Imaging IPO Registration Document (S-1)
Lumexa Imaging has filed to go public with an IPO on the NASDAQ.
Diagnostic imaging provider Lumexa Imaging Holdings files for an estimated $200 million IPO
Lumexa Imaging Holdings, which provides diagnostic imaging services through outpatient centers, filed on Monday with the SEC to raise what we estimate could be up to $200 million in an initial public ...